Loading...
Barekyne operates under the strictest pharmaceutical-grade quality standards. All products are manufactured in WHO-GMP certified facilities with full ISO 9001:2015 compliance.
Need documents immediately? Request certified copies via WhatsApp for instant delivery.
Request via WhatsAppGovernment and international body certifications covering manufacturing, quality, and legal compliance.
Issued by: World Health Organization (WHO)
Confirms our manufacturing facility meets World Health Organization Good Manufacturing Practices — the global gold standard for pharmaceutical-grade production.
Issued by: State Drugs / Cosmetic Licensing Authority, Haryana
State-issued license authorizing Barekyne to legally manufacture and sell cosmetic and cosmeceutical skincare formulations across India. Issued under the Drugs & Cosmetics Act.
Issued by: International Organization for Standardization
Certifies our Quality Management System meets international standards for consistent product quality, traceability, and continuous improvement across all operations.
Issued by: State Licensing Authority, Haryana
State-issued drug manufacturing license authorizing production of regulated cosmeceutical formulations. Separate from the cosmetic license and required for prescription-grade products.
Issued by: Goods and Services Tax Network (GSTN), India
GST registration confirming Barekyne is a legally registered business entity in India, eligible for B2B invoice generation with valid GSTIN for input tax credit.
Issued by: Ministry of Micro, Small and Medium Enterprises, Govt. of India
Udyam registration confirming Barekyne's MSME status — making franchise partners eligible for priority sector lending and government-backed MSME support schemes.
Scientific validation reports supporting product claims and ingredient efficacy.
Accelerated stability data confirming all 5 SKUs maintain potency and safety across India's extreme temperature and humidity ranges (40°C / 75% RH).
Dermatologist-conducted patch test and HRIPT (Human Repeat Insult Patch Test) data confirming product safety for sensitive and melanin-rich Indian skin.
In-vitro and clinical study summaries supporting key claims — including 90% melanin inhibition data for Bare-Hydra Lotion and tyrosinase inhibition data for night cream actives.
Franchise partners, distributors, and institutional buyers can request the full compliance documentation package — including notarized copies, test batch records, and product dossiers.